Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (341-350 of 1,024) with videos related to

Pageof 103
Sort By:
Photochemistry and Photobiology|June 20, 2007
Comparison of stability predictions and simulated unfolding of rhodopsin structuresOznur Tastan, Esther Yu, Madhavi Ganapathiraju, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2004
Structural basis of endothelial lipase tropism for HDLUli C Broedl, Weijun Jin, Ilia V Fuki, et al.
Journal of Lipid Research|February 27, 2007
Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivoRobert J Brown, Gwen C Miller, Nathalie Griffon, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Cardiology in Review|December 21, 2011
The evolution and refinement of traditional risk factors for cardiovascular diseaseEmil M deGoma, Joshua W Knowles, Fabio Angeli, et al.
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Journal of Lipid Research|August 1, 2006
Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-IIUli C Broedl, Weijun Jin, Ilia V Fuki, et al.
Journal of the American College of Cardiology|November 5, 2011
The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery diseaseParin J Patel, Amit V Khera, Kashif Jafri, et al.
Cardiovascular Drugs and Therapy|March 6, 2024
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical TrialsRobert S Rosenson, Daniel J Rader, Shazia Ali, et al.
Circulation|August 24, 2011
Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transportShigenori Yamamoto, Hiroyuki Tanigawa, Xiaoyu Li, et al.
Pageof 103

Showing results (341-350 of 1,024) with videos related to

Sort By:
Pageof 103
Photochemistry and Photobiology|June 20, 2007
Comparison of stability predictions and simulated unfolding of rhodopsin structuresOznur Tastan, Esther Yu, Madhavi Ganapathiraju, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2004
Structural basis of endothelial lipase tropism for HDLUli C Broedl, Weijun Jin, Ilia V Fuki, et al.
Journal of Lipid Research|February 27, 2007
Glycosylation of endothelial lipase at asparagine-116 reduces activity and the hydrolysis of native lipoproteins in vitro and in vivoRobert J Brown, Gwen C Miller, Nathalie Griffon, et al.
The American Journal of Cardiology|August 10, 2010
On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study)Amit V Khera, Megan L Wolfe, Christopher P Cannon, et al.
Cardiology in Review|December 21, 2011
The evolution and refinement of traditional risk factors for cardiovascular diseaseEmil M deGoma, Joshua W Knowles, Fabio Angeli, et al.
Nature Clinical Practice. Cardiovascular Medicine|May 29, 2008
Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemiaFrederick F Samaha, James McKenney, Leanne T Bloedon, et al.
Journal of Lipid Research|August 1, 2006
Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-IIUli C Broedl, Weijun Jin, Ilia V Fuki, et al.
Journal of the American College of Cardiology|November 5, 2011
The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery diseaseParin J Patel, Amit V Khera, Kashif Jafri, et al.
Cardiovascular Drugs and Therapy|March 6, 2024
Evinacumab Reduces Triglyceride-Rich Lipoproteins in Patients with Hyperlipidemia: A Post-Hoc Analysis of Three Randomized Clinical TrialsRobert S Rosenson, Daniel J Rader, Shazia Ali, et al.
Circulation|August 24, 2011
Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transportShigenori Yamamoto, Hiroyuki Tanigawa, Xiaoyu Li, et al.
Pageof 103